SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons sharp rebound is being linked by traders to Morgan Stanley naming it a top pick on AWS growth and AI prospects, as well as AWS making its Trainium chips easier for developers to use. Bulls welcome the move and point to cloud and AI momentum, while skeptics question whether it can hold amid heavy capex and recent volatility.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares surged after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the case for an FDA resubmission, though approval is still pending. Traders are debating the significance of dizziness reported among treated patients and speculating about a short squeeze amid volatile trading.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A stronger-than-expected third quarter and an upbeat 2027 EBITDA outlook are driving CLFs rally, with bullish traders anticipating short covering. Others warn the outlook depends on steel prices and remain focused on the companys debt, while some see the move as a sell-the-news bounce.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid a steep post-IPO selloff, with traders citing insider share sales and upcoming lockup releases as added supply pressure alongside concerns about valuation, growth and its OpenAI exposure. Bears warn of further downside, while bulls argue the decline is overdone and are buying the dip; some also attribute weakness to a broader AI and semiconductor-sector retreat.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is drawing attention ahead of its Q3 report after raising its outlook twice, with traders citing higher royalties from its AI-focused Vertical Power Delivery licensing. Bulls see the pullback as a buying opportunity and expect strong results, while others point to the stocks volatility and selling despite the improved outlook.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reported takeover interest from Lundbeck is driving speculation about a potential bid or bidding war and heightened trading activity. Xeris has said it is not for sale, leaving traders divided between treating the chatter as a credible deal catalyst and focusing on Recorlev growth and XP-8121s pipeline prospects.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea is under pressure after a sharp selloff and technical breakdown, with traders citing recent insider share sales and an analyst downgrade as possible catalysts; some also point to weakness in Indonesian and regional markets. Bears fear further declines and criticize management, while bulls argue the business remains fundamentally strong and view the pullback as a buying opportunity.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios FDA expansion of Anktiva plus BCG to papillary-only bladder cancer, alongside positive long-term trial data, is the main focus. The share-price decline despite those developments has prompted debate over profit-taking, broader biotech weakness and options activity, while some traders allege manipulation without substantiation.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is drawing attention amid a persistent selloff and weak solar-sector sentiment, with traders pointing to interest-rate sensitivity, policy and financing concerns, and analyst target cuts. The debate is whether its AI data-center, battery-storage and virtual-power-plant initiativesand perceived high short interestcould offset those pressures; some traders view them as a potential turnaround catalyst, while others remain bearish.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy prompted hopes for a rebound after a sharp selloff, but traders remain focused on the companys debt burden, bond-market stress, and ability to finance expansion. Bulls point to AI demand and contracted backlog as support, while bears argue those commitments may not translate into enough cash flow to cover financing needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Cycurion Gaining Friday?

Cycurion shares surged 48% after regaining Nasdaq compliance. The company cited major contracts, growth plans and legal resolution.read more...

12 Industrials Stocks Moving In Friday's Intraday Session

Gainers

Flux Power Holdings (NASDAQ:FLUX) shares rose 77.2% to $0.72 during Friday's regular session. The market value of their outstanding shares is at $8.7 million.
Cycurion (NASDAQ:CYCU) stock rose 48.32% toread more...

Market Movers Go Wild and Lead Fresh Wave of Action

Today’s market action is being shaped by a striking mix of listings, including Alpha Modus Holdings (NASDAQ:AMOD), Stablecoin Development (NYSEAMERICAN:SDEV), Cycurion (NASDAQ:CYCU), ImmunityBio (NASDAQ:IBRX), XIAO-I Corporation (NASDAQ:AIXI), and NeOnc Technologies Holdings (NASDAQ:NTHI).

Cycurion Clears Nasdaq $1 Hurdle as CYCU Keeps Trading

Cycurion (NASDAQ:CYCU) has cleared a critical Nasdaq listing hurdle, giving the cybersecurity and AI-focused company another important development as it enters October. Nasdaq confirmed that Cycurion satisfied the condition set by its September 9 Hearings Panel decision by regaining compliance with the exchange’s $1.00 minimum bid-price requirement.

All You Need to Know About Cycurion, Inc. (CYCU) Rating Upgrade to Buy

Cycurion, Inc. (CYCU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cycurion Authorized To Repurchase Up To $500K Of Shares

(RTTNews) - Cycurion, Inc. (CYCU), a provider of cybersecurity, public safety technology, and managed services solutions, said on Monday that its board has authorized a share repurchase program of up to $500,000 over the next 12 months...

Vestis (VSTS) Q3 Earnings Surpass Estimates

Vestis (VSTS) delivered earnings and revenue surprises of +63.64% and -1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Alarm.com Holdings (ALRM) Q2 Earnings and Revenues Top Estimates

Alarm.com (ALRM) delivered earnings and revenue surprises of +18.46% and +4.87%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CYCU Stock Pulls Back After Nearly 500% Jump Driven By Record $54.6M Government Contract 

Equity

Cycurion announced on Thursday that it had secured a 10-year, $54.6 million agreement supporting the modernization of a state Health and Human Services system.


Cycurion Adds Another 37% After Stunning 496% SurgeWhat's Fueling the Rally?

Cycurion (CYCU) jumps on a record $54.6M contract with a top consulting firm. Read the latest stock price action and earnings outlook.read more...

Cycurion, Inc. engages in custom solutions to organizations for information technology (IT) and cybersecurity needs. It offers consulting and advisory, managed IT, and managed security services. The company was founded by Alvin McCoy and Emmit McHenry in 2017 and is headquartered in McLean, VA.

Cycurion Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>The contract is expected to generate more than $5 million in annual revenue, with work beginning in November 2026.</li><li>It aligns with Cycurion's strategy of shifting away from lower-margin legacy work toward higher-margin, recurring government engagements.</li><li>Cycurion also announced that it has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 3.34 million of the company’s common stock.</li></ul>Shares of Cycurion (CYCU) slipped after the opening bell on Friday, after posting its biggest single-day gain on record in the previous session on securing the largest contract in the company’s history.As of this writing,&nbsp;<a href="https://stocktwits.com/symbol/CYCU">CYCU stock</a> traded lower by over 24% in morning trade. The move follows a 500% jump in the previous session.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260731_095228847_1c77a2c606.png" alt="koyfin_20260731_095228847.png" width="2400" height="1240"><figcaption>CYCU stock historical daily gains. | Source: Koyfin</figcaption></figure>On Stocktwits, retail sentiment around the IT and cybersecurity company rose to ‘extremely bullish’ from ‘bullish’ territory over the past day. Chatter rose to ‘extremely high’ from ‘high’ levels, with platform data showing a message volume jump of over 21,000% in the last 24 hours.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_07_31_093243_8c01ee870d.png" alt="Screenshot 2026-07-31 093243.png" width="1306" height="1234"><figcaption>CYCU stock retail sentiment and message volume on July 31 as of 9:45 a.m. ET | Source: Stocktwits&nbsp;</figcaption></figure><h2 class="st-heading-2">The Record $54.6 Million Government Contract&nbsp;</h2>The company on Thursday announced that it had won a 10-year contract worth approximately $54.6 million through a partnership with a top-five global consulting firm to support the modernization and secure operation of a state Health and Human Services (HHS) system. The agreement is expected to generate more than $5 million in annual revenue, with work scheduled to begin in November 2026.The award marks a milestone for Cycurion, whose market capitalization of around $18 million at the time of writing was well below the contract's total value."This contract will play a major role in Cycurion's progression and expansion and reflects confidence in our ability to deliver secure, mission-critical solutions at scale," Chairman and CEO L. Kevin Kelly stated.&nbsp;He added that the project strengthens the company's position in the state, local, and education (SLED) market while creating opportunities for additional work with both the government agency and its consulting partner.<h2 class="st-heading-2">Long-Term Government Strategy&nbsp;</h2>The contract aligns with Cycurion's strategy of shifting away from lower-margin legacy work toward higher-margin, recurring government engagements, reiterated during the first-quarter (Q1) earnings call.&nbsp;Cycurion is also working to maintain its Nasdaq listing. The company requested a hearing to&nbsp;appeal the delisting determination it received earlier this month. The hearing has been scheduled and is expected to take place in August 2026.Meanwhile, Cycurion announced on Friday that it has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 3.34 million of the company’s common stock. The purchase will be at an exercise price of $1.35 per share for gross cash proceeds of approximately $4.5 million.The firm said it intends to use the net proceeds from the warrant inducement transaction for working capital and other general corporate purposes.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvda-stock-bargain-trading-30-percent-below-fair-value/cZN43deRJP5">NVDA Stock Is A ‘Bargain’ Trading 30% Below $280 Fair Value, Morningstar Says</a>

Close up of stock market chart on a glowing particle world map. (Source: Getty Images)

Cycurion announced on Thursday that it had secured a 10-year, $54.6 million agreement supporting the modernization of a state Health and Human Services system.

CYCU Stock Pulls Back After Nearly 500% Jump Driven By Record $54.6M Government Contract

Vanguard Extended Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.27
Prev Close	$2.19
Open	$2.24
Dividend Yield	0.00%
50-Day Moving Average	$3.74
Beta	1.08
Avg. Volume	231,820.47
PE Ratio	-0.07

52-Week High	$63.33
52-Week Low	$2.08
Market Capitalization	$7.07M
EPS (Annual)	-$107.55
Price to Book	0.14
Revenue Per Employee	$204,508.74

Feed

News

Sentiment

Fundamentals

Info

CYCU Fundamentals